{"id":"W2128450617","doi":"10.1136/thoraxjnl-2013-203600","title":"Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone","year":2013,"lang":"en","type":"article","venue":"Thorax","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"National Institute for Health and Care Research; Teva Pharmaceutical Industries; Sanofi; Wake Forest University; Amgen; Pfizer; Genentech; AstraZeneca; UCB Pharma; American Academy of Allergy Asthma and Immunology; GlaxoSmithKline","keywords":"Medicine; Fluticasone propionate; Asthma; Exacerbation; Adverse effect; Corticosteroid; Internal medicine; Fluticasone; Clinical endpoint; Mometasone furoate; Rate ratio; Evening; Anesthesia; Randomized controlled trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00291398,0.0007883756,0.002191901,0.0003942118,0.0002319815,0.0006629871,0.0006257456,0.001601827,0.003118337],"category_scores_gemma":[0.003004943,0.0005307619,0.002025745,0.0002808162,0.0008084803,0.0005968835,0.0004337601,0.001546805,0.000380515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004151929,"about_ca_system_score_gemma":0.0004641115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003434123,"about_ca_topic_score_gemma":0.0005792075,"domain_scores_codex":[0.9985269,0.0009283592,0.0001318038,0.000170924,0.0001313859,0.0001105256],"domain_scores_gemma":[0.9975848,0.001165574,0.000675497,0.0001314719,0.0000858202,0.0003567704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9702466,0.005078148,0.00119557,0.0008320643,0.0009358912,0.00001954355,0.00003083129,0.0002210743,0.003617423,0.00004265748,0.0001412668,0.01763882],"study_design_scores_gemma":[0.5199865,0.4630805,0.01240729,0.0001115791,0.001402583,0.00008371974,0.00002598738,0.0005499462,0.001651201,0.000128991,0.0005500256,0.00002171252],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894919,0.008353775,0.0003100328,0.000209246,0.0002533577,0.0005677734,0.000204401,0.00002258226,0.000586883],"genre_scores_gemma":[0.9951177,0.002564613,0.0006056095,0.000171442,0.0003193841,0.0004129599,0.0001853742,0.000006207431,0.0006167484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003118337,"threshold_uncertainty_score":0.01541078,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01786435224473766,"score_gpt":0.2812869307063584,"score_spread":0.2634225784616207,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}